Randomized Trialhigh evidence
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
The New England journal of medicine·April 18, 2024·PMID 38587239
Why it mattersThis is the first large RCT to show a survival benefit with a microaxial flow pump in infarct-related cardiogenic shock, addressing a long-standing evidence gap. The mortality reduction must be weighed against a significant increase in complications.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled